Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Jaime de la Fuente

Matched on ORCID iD 0000-0002-2069-5052; OpenAlex author ID A5018927289. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 8

  1. Multimodal Pancreatic Cancer Detection Using Methylated DNA Biomarkers in Pancreatic Juice and Plasma CA 19-9: A Prospective Multicenter Study. Co-author DOI 10.1016/j.cgh.2024.07.048↗
  2. Long-Term Outcomes and Risk of Pancreatic Cancer in Intraductal Papillary Mucinous Neoplasms. Co-author DOI 10.1001/jamanetworkopen.2023.37799↗
  3. Pancreatic Cancer is More Frequently Early Stage at Diagnosis in Surgically Resected Intraductal Papillary Mucinous Neoplasms With Preoperative Surveillance. Co-author DOI 10.1016/j.gastha.2022.07.004↗
  4. Chronic Pancreatitis Is a Risk Factor for Pancreatic Cancer, and Incidence Increases With Duration of Disease: A Systematic Review and Meta-analysis. First author DOI 10.14309/ctg.0000000000000463↗
  5. High Detection Rates of Pancreatic Cancer Across Stages by Plasma Assay of Novel Methylated DNA Markers and CA19-9. Co-author DOI 10.1158/1078-0432.ccr-20-0235↗
  6. How I Approach Screening for Pancreatic Cancer Co-author DOI 10.14309/ajg.0000000000001305↗
  7. Corrigendum to "Peripheral blood monocyte counts are elevated in the pre-diagnostic phase of pancreatic cancer: A population based study" [Pancreatology. 19 (8… Co-author DOI 10.1016/j.pan.2020.03.006↗
  8. Peripheral blood monocyte counts are elevated in the pre-diagnostic phase of pancreatic cancer: A population based study. Co-author DOI 10.1016/j.pan.2019.10.002↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shounak Majumder · 8 shared papers, 2019–2025 · strength 1.30
  2. Suresh T. Chari · 5 shared papers, 2019–2023 · strength 0.68
  3. Sonal Gandhi · 2 shared papers, 2022–2025 · strength 0.40
  4. Ferga C. Gleeson · 2 shared papers, 2022–2025 · strength 0.29
  5. Vinay Chandrasekhara · 2 shared papers, 2022–2025 · strength 0.29
  6. Douglas W. Mahoney · 2 shared papers, 2021–2025 · strength 0.28
  7. John B. Kisiel · 2 shared papers, 2021–2025 · strength 0.28
  8. Rondell Patrell Graham · 2 shared papers, 2022–2023 · strength 0.27
  9. Arjun Chatterjee · 2 shared papers, 2022–2023 · strength 0.27
  10. Santhi Swaroop Vege · 2 shared papers, 2022–2023 · strength 0.27
  11. Fay Kastrinos · 1 shared paper, 2021 · strength 0.22
  12. Sanne A.M. Hoogenboom · 1 shared paper, 2025 · strength 0.17
  13. Jeanin Elise van Hooft · 1 shared paper, 2025 · strength 0.17
  14. Megan M.L. Engels · 1 shared paper, 2025 · strength 0.17
  15. Dhruv Sarwal · 1 shared paper, 2025 · strength 0.17
  16. Bhaumik S. Brahmbhatt · 1 shared paper, 2025 · strength 0.17
  17. Frank Lukens · 1 shared paper, 2025 · strength 0.17
  18. Eric J. Vargas Valls · 1 shared paper, 2025 · strength 0.17
  19. Derk C.F. Klatte · 1 shared paper, 2025 · strength 0.17
  20. Michael B. Wallace · 1 shared paper, 2025 · strength 0.17
  21. Victoria Gómez · 1 shared paper, 2025 · strength 0.17
  22. Massimo Raimondo · 1 shared paper, 2025 · strength 0.17
  23. Naoki Takahashi · 1 shared paper, 2023 · strength 0.15
  24. Lizhi Zhang · 1 shared paper, 2022 · strength 0.12
  25. Sean Patrick Cleary · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.